Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Commission Suddenly Reins In MDR Proposal Feedback Period To One Week

Executive Summary

There is no time to lose in commenting on the MDR extension proposal. Less than a day after the European Commission offered stakeholders eight weeks to comment it has axed this to one week.

You may also be interested in...



Commenting On the EU MDR Proposal? What You Need To Know About Finer Details

18 January is the deadline to respond to the European Commission’s 6 January proposal to amend the Medical Device Regulation by extending legacy product transition deadlines. This article explains how changes are expected to be made.

European Commission Invites Comments On Its Critical MDR Proposal

The EU is looking at extending transition deadlines for compliance under the Medical Device Regulation as a matter of urgency. Now the European Commission is inviting feedback on its proposed measures.

Moves For Go Ahead For MDR Proposal To Be Discussed At European Parliament

The European Commission’s proposal to extend transition timelines for legacy devices in the context of the Medical Device Regulation is already on the move. There are still questions, however, about whether a fast-track adoption is in the best interests of the medtech sector.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147531

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel